ArticleClinical & translational immunology2021

Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform.

Gautam N Shenoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.